GTBP Stock Analysis: Buy, Sell, or Hold?
GTBP - GT Biopharma Inc. Common Stock
$0.30
0.01 (4.03%)
â˛
5d:
+7.02%
30d:
+0.0%
90d:
-32.24%
WAIT
LOW Confidence
Analysis Updated: Aug 27, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When GTBP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GTBP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GTBP is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GTBP is currently trading at $0.30, which is considered fair relative to its 30-day fair value range of $0.29 to $0.33.
Technical Outlook: Technically, GTBP is in a downtrend. Immediate support is located at $0.27, while resistance sits at $0.32. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: GTBP scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.00 (+934.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GTBP is in a downtrend. Immediate support is located at $0.27, while resistance sits at $0.32. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: GTBP scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $3.00 (+934.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.29 -
$0.33
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
92.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 934.1% below Wall St target ($3.00)
- WARNING: Composite score 53/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.29 -
$0.33
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.27
Resistance Level
$0.32
Current Trend
Downtrend
Technical data as of
Aug 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.91
Wall Street Target
$3.00
(+934.1%)
Share & Embed Analysis
Last updated: August 27, 2026 3:50 PM ET
Data refreshes hourly during market hours. Next update: 4:50 PM
Data refreshes hourly during market hours. Next update: 4:50 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GTBP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 42 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 49 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 39 SELL |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$23 | 46 HOLD |
